Crawford Brown

About

Crawford Brown, PhD is a global biologics CMC pioneer in the translation of new technologies from academic idea to clinical practice. Over an industrial career of 35 years, he has made a meaningful difference to patient outcomes leading development through to marketing approval of recombinant proteins, neurotoxins, monoclonal antibodies and vaccines. Most recently as SVP Biologics and Small Molecule API in Allergan Inc. he led CMC R&D focused on ophthalmology including optogenetics following the acquisition of Retrosense and CRISPR in vivo gene editing in collaboration with Editas Medicine.

Investment Focus

Location

Chester, UK